Recent Reports About HIFU'Troubling'Recent Reports About HIFU'Troubling '

Despite new reports of HIFU for focalized therapy of prostate cancer, Dr Chodak remains unconvinced of its evidence.Medscape Urology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Urology Commentary Source Type: news

Related Links:

Condition:   Cancer of Prostate Intervention:   Device: " Ablatherm Foc/Dyn " or " Focal One " HIFU treatment Sponsor:   EDAP TMS S.A. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionPresence or not of an extra-target NCSC in the untreated part of the gland had no impact on RTFS. NCSC lesion can be left untreated and actively monitored. RTFS was 80% at 3  years which support the concept of focal/partial treatment as a treatment option of CSC prostate cancer.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Prostate cancer (CaP) in men represents the main cancer cause of years lost due to disabilities in most European countries [1]. Theoretically, focal therapy of CaP enables both cancer control and low treatment related side effects, leading to a reduction of years lost due to disabilities.
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Tags: Original article Source Type: research
CONCLUSIONS: Targeted MRI/TRUS fusion-guided focal HIFU allows local tumor ablation, but is not free from limitations. The procedure has good functional outcomes and a quick recovery. Multicenter trials with more patients are required to determine the procedure´s role in the prostate cancer therapy algorithm. PMID: 30093211 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Tags: Urol Oncol Source Type: research
ConclusionHigh-intensity focused ultrasound appears to be a safe alternative for the treatment of localized prostate cancer, especially for low-risk localized prostate cancer. In our experience, this technique offers advantages in preserving urinary continence, and the medium-term oncological results are encouraging. Given the natural progression of prostate cancer, long-term studies with a larger number of cases are needed to corroborate these results.ResumenIntroducciónHoy en día, el tratamiento del cáncer de próstata localizado busca minimizar el impacto en la función sexual y la conti...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
We assessed the outcomes of high-intensity focused ultrasound for the primary treatment of localized prostate cancer in a retrospective series. This represents one of the largest published series of intermediate and high-risk patients.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Source Type: research
ConclusionsBoth techniques have comparable functional results, although the somewhat poorer oncological results for HIFU reflect a steeper learning curve, which could lead to its use in centers with high volumes of patients.ResumenContexto y objetivoEl diagnóstico cada vez más precoz del cáncer de próstata obliga a buscar alternativas terapéuticas con buenos resultados oncológicos, que a su vez faciliten una buena calidad de vida a largo plazo. La presente revisión analiza los resultados de 2 terapias mínimamente invasivas en el tratamiento del cáncer localizad...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionsFocal therapy for select patients with clinically significant nonmetastatic prostate cancer is effective in the medium term and has a low probability of side effects.Patient summaryIn this multicentre study of 625 patients undergoing focal therapy using high-intensity focused ultrasound (HIFU), failure-free survival, metastasis-free survival, cancer-specific survival, and overall survival were 88%, 98%, 100%, and 99%, respectively. Urinary incontinence (any pad use) was 2%. Focal HIFU therapy for patients with clinically significant prostate cancer that has not spread has a low probability of side effects and is effective at 5 yr.
Source: European Urology - Category: Urology & Nephrology Source Type: research
(MedPage Today) -- Failure-free survival of almost 90% at 5 years
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
ConclusionsBoth techniques have comparable functional results, although the somewhat poorer oncological results for HIFU reflect a steeper learning curve, which could lead to its use in centers with high volumes of patients.ResumenContexto y objetivoEl diagnóstico cada vez más precoz del cáncer de próstata obliga a buscar alternativas terapéuticas con buenos resultados oncológicos, que a su vez faciliten una buena calidad de vida a largo plazo. La presente revisión analiza los resultados de 2 terapias mínimamente invasivas en el tratamiento del cáncer localizad...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Health | High Intensity Focused Ultrasound Therapy | Prostate Cancer | Urology & Nephrology